Neurodegeneration and neuroregeneration in chagas disease

Advances in Parasitology

Volumn 76, Issue , 2011, Pages 195-233

  Chuenkova, Marina V ^a   PereiraPerrin, Mercio ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chagas disease; Cytokine; Nervous system; Neurodegeneration; Parasite derived neurotrophic factor; Parasympathetic ganglia; T. cruzi; Trans sialidase

Indexed keywords

ACYLTRANSFERASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GAMMA INTERFERON; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLYCOGEN SYNTHASE KINASE 3BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYELIN BASIC PROTEIN; NERVE GROWTH FACTOR; NEURONAL NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN KINASE C; RAS PROTEIN; SIALIDASE; TRANSCRIPTION FACTOR FKHRL1; TUMOR NECROSIS FACTOR ALPHA; TYROSINE 3 MONOOXYGENASE; TYROSINE KINASE RECEPTOR; UNINDEXED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; VESICULAR ACETYLCHOLINE TRANSPORTER;

ADRENERGIC STIMULATION; APOPTOSIS; AUTOIMMUNITY; BOOK; CELL DIFFERENTIATION; CELL STRUCTURE; CELL SURVIVAL; CHAGAS DISEASE; CHOLINERGIC STIMULATION; COLON MOTILITY; CRYPTOSPORIDIUM PARVUM; CYTOKINE PRODUCTION; CYTOPLASM; CYTOTOXIC LYMPHOCYTE; CYTOTOXICITY; DYSAUTONOMIA; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ESOPHAGUS ACHALASIA; ESOPHAGUS MOTILITY; GASTROINTESTINAL MOTILITY DISORDER; GLIA CELL; HEART FAILURE; HEART MUSCLE CELL; HOST CELL; HUMAN; INFLAMMATION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LEISHMANIA; MACROPHAGE; MALNUTRITION; NATURAL KILLER CELL; NERVE CELL; NERVE DEGENERATION; NERVE REGENERATION; NEUROTRANSMISSION; NONHUMAN; OXIDATIVE STRESS; PARASITISM; PATHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; PLASMODIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SCHWANN CELL; STOMACH EMPTYING; THEILERIA; TOXOPLASMA GONDII; TRYPANOSOMA CRUZI; WEIGHT REDUCTION;

MAMMALIA; TRYPANOSOMA CRUZI;

EID: 80052146841     PISSN: 0065308X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385895-5.00009-8     Document Type: Chapter

References (236)

1. Adad S.J., Cancado C.G., Etchebehere R.M., Teixeira V.P., Gomes U.A., Chapadeiro E., et al. Neuron count reevaluation in the myenteric plexus of chagasic megacolon after morphometric neuron analysis. Virchows Arch. 2001, 438:254-258.
2. Adesse D., Iacobas D.A., Iacobas S., Garzoni L.R., Meirelles Mde N., Tanowitz H.B., et al. Transcriptomic signatures of alterations in a myoblast cell line infected with four distinct strains of Trypanosoma cruzi. Am. J. Trop. Med. Hyg. 2010, 82:846-854.
3. Agusti R., Couto A.S., Campetella O.E., Frasch A.C., de Lederkremer R.M. The trans-sialidase of Trypanosoma cruzi is anchored by two different lipids. Glycobiology 1997, 7:731-735.
4. Akpan N., Caradonna K., Chuenkova M.V., PereiraPerrin M. Chagas' disease parasite-derived neurotrophic factor activates cholinergic gene expression in neuronal PC12 cells. Brain Res. 2008, 1217:195-202.
5. Aliberti J.C., Cardoso M.A., Martins G.A., Gazzinelli R.T., Vieira L.Q., Silva J.S. Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes. Infect. Immun. 1996, 64:1961-1967.
6. Aliberti J.C., Souto J.T., Marino A.P., Lannes-Vieira J., Teixeira M.M., Farber J., et al. Modulation of chemokine production and inflammatory responses in interferon-gamma- and tumor necrosis factor-R1-deficient mice during Trypanosoma cruzi infection. Am. J. Pathol. 2001, 158:1433-1440.
7. Almeida-Leite C.M., Galvao L.M., Afonso L.C., Cunha F.Q., Arantes R.M. Interferon-gamma induced nitric oxide mediates in vitro neuronal damage by Trypanosoma cruzi-infected macrophages. Neurobiol. Dis. 2007, 25:170-178.
8. Alvarez P., Leguizamon M.S., Buscaglia C.A., Pitcovsky T.A., Campetella O. Multiple overlapping epitopes in the repetitive unit of the shed acute-phase antigen from Trypanosoma cruzi enhance its immunogenic properties. Infect. Immun. 2001, 69:7946-7949.
9. Alves M.J., Colli W. Role of the gp85/trans-sialidase superfamily of glycoproteins in the interaction of Trypanosoma cruzi with host structures. Subcell. Biochem. 2008, 47:58-69.
10. Alves J.B., Machado C.R. Changes in acetylcholinesterase-positive nerves of the submandibular salivary gland during experimental infection with a protozoon, Trypanosoma cruzi, in rats. Arch. Oral Biol. 1984, 29:647-651.
11. Amaya M.F., Watts A.G., Damager I., Wehenkel A., Nguyen T., Buschiazzo A., et al. Structural insights into the catalytic mechanism of Trypanosoma cruzi trans-sialidase. Structure 2004, 12:775-784.
12. Amorim D.D., Marin Neto J.A. Functional alterations of the autonomic nervous system in Chagas' heart disease. Sao Paulo Med. J. 1995, 113:772-784.
13. Andrade L.O., Andrews N.W. The Trypanosoma cruzi-host-cell interplay: location, invasion, retention. Nat. Rev. Microbiol. 2005, 3:819-823.
14. Aoki Mdel P., Cano R.C., Pellegrini A.V., Tanos T., Guinazu N.L., Coso O.A., et al. Different signaling pathways are involved in cardiomyocyte survival induced by a Trypanosoma cruzi glycoprotein. Microbes Infect. 2006, 8:1723-1731.
15. Aoki M.P., Guinazu N.L., Pellegrini A.V., Gotoh T., Masih D.T., Gea S. Cruzipain, a major Trypanosoma cruzi antigen, promotes arginase-2 expression and survival of neonatal mouse cardiomyocytes. Am. J. Physiol. Cell Physiol. 2004, 286:C206-C212.
16. Arantes R.M., Marche H.H., Bahia M.T., Cunha F.Q., Rossi M.A., Silva J.S. Interferon-gamma-induced nitric oxide causes intrinsic intestinal denervation in Trypanosoma cruzi-infected mice. Am. J. Pathol. 2004, 164:1361-1368.
17. Arevalo J.C., Wu S.H. Neurotrophin signaling: many exciting surprises!. Cell. Mol. Life Sci. 2006, 63:1523-1537.
18. Atwood J.A., Weatherly D.B., Minning T.A., Bundy B., Cavola C., Opperdoes F.R., et al. The Trypanosoma cruzi proteome. Science 2005, 309:473-476.
19. Aukrust P., Gullestad L., Ueland T., Damas J.K., Yndestad A. Inflammatory and anti-inflammatory cytokines in chronic heart failure: potential therapeutic implications. Ann. Med. 2005, 37:74-85.
20. Baroldi G., Oliveira S.J., Silver M.D. Sudden and unexpected death in clinically 'silent' Chagas' disease. A hypothesis. Int. J. Cardiol. 1997, 58:263-268.
21. Barry E.F., Felquer F.A., Powell J.A., Biggs L., Stomski F.C., Urbani A., et al. 14-3-3:Shc scaffolds integrate phosphoserine and phosphotyrosine signaling to regulate phosphatidylinositol 3-kinase activation and cell survival. J. Biol. Chem. 2009, 284:12080-12090.
22. Bassotti G., Villanacci V., Antonelli E., Morelli A., Salerni B. Enteric glial cells: new players in gastrointestinal motility?. Lab. Invest. 2007, 87:628-632.
23. Bestetti R.B. Role of parasites in the pathogenesis of Chagas' cardiomyopathy. Lancet 1996, 347:913-914.
24. Bestetti R.B., Muccillo G. Clinical course of Chagas' heart disease: a comparison with dilated cardiomyopathy. Int. J. Cardiol. 1997, 60:187-193.
25. Beucher M., Norris K.A. Sequence diversity of the Trypanosoma cruzi complement regulatory protein family. Infect. Immun. 2008, 76:750-758.
26. Biolo A., Ribeiro A.L., Clausell N. Chagas cardiomyopathy-where do we stand after a hundred years?. Prog. Cardiovasc. Dis. 2010, 52:300-316.
27. Bonni A., Ginty D.D., Dudek H., Greenberg M.E. Serine 133-phosphorylated CREB induces transcription via a cooperative mechanism that may confer specificity to neurotrophin signals. Mol. Cell. Neurosci. 1995, 6:168-183.
28. Boyd J.G., Gordon T. Neurotrophic factors and their receptors in axonal regeneration and functional recovery after peripheral nerve injury. Mol. Neurobiol. 2003, 27:277-324.
29. Brunet A., Datta S.R., Greenberg M.E. Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr. Opin. Neurobiol. 2001, 11:297-305.
30. Burkauskiene A., Mackiewicz Z., Virtanen I., Konttinen Y.T. Age-related changes in myocardial nerve and collagen networks of the auricle of the right atrium. Acta Cardiol. 2006, 61:513-518.
31. Buscaglia C.A., Campo V.A., Frasch A.C., Di Noia J.M. Trypanosoma cruzi surface mucins: host-dependent coat diversity. Nat. Rev. Microbiol. 2006, 4:229-236.
32. Buschiazzo A., Amaya M.F., Cremona M.L., Frasch A.C., Alzari P.M. The crystal structure and mode of action of trans-sialidase, a key enzyme in Trypanosoma cruzi pathogenesis. Mol. Cell 2002, 10:757-768.
33. Caetano L.C., Zucoloto S., Kawasse L.M., Toldo M.P., do Prado J.C. Influence of Trypanosoma cruzi chronic infection in the depletion of esophageal neurons in Calomys callosus. Dig. Dis. Sci. 2006, 51:1796-1800.
34. Caetano L.C., Zucoloto S., Kawasse L.M., Toldo M.P., do Prado J.C. Does cyclophosphamide play a protective role against neuronal loss in chronic T. cruzi infection?. Dig. Dis. Sci. 2008, 53:2929-2934.
35. Camargos E.R., Haertel L.R., Machado C.R. Preganglionic fibres of the adrenal medulla and cervical sympathetic ganglia: differential involvement during experimental American trypanosomiasis in rats. Int. J. Exp. Pathol. 1996, 77:115-124.
36. Camargos E.R., Franco D.J., Garcia C.M., Dutra A.P., Teixeira A.L., Chiari E., et al. Infection with different Trypanosoma cruzi populations in rats: myocarditis, cardiac sympathetic denervation, and involvement of digestive organs. Am. J. Trop. Med. Hyg. 2000, 62:604-612.
37. Campos J.V., Tafuri W.L. Chagas enteropathy. Gut 1973, 14:910-919.
38. Caradonna K., Pereiraperrin M. Preferential brain homing following intranasal administration of Trypanosoma cruzi. Infect. Immun. 2009, 77:1349-1356.
39. Carmen J.C., Sinai A.P. Suicide prevention: disruption of apoptotic pathways by protozoan parasites. Mol. Microbiol. 2007, 64:904-916.
40. Cavallesco R., Pereira M.E. Antibody to Trypanosoma cruzi neuraminidase enhances infection in vitro and identifies a subpopulation of trypomastigotes. J. Immunol. 1988, 140:617-625.
41. Chernousov M.A., Carey D.J. Schwann cell extracellular matrix molecules and their receptors. Histol. Histopathol. 2000, 15:593-601.
42. Cheung E.C., Slack R.S. Emerging role for ERK as a key regulator of neuronal apoptosis. Sci. STKE 2004, PE45.
43. Chimelli L., Scaravilli F. Trypanosomiasis. Brain Pathol. 1997, 7:599-611.
44. Chuenkova M.V., Pereira M.A. A trypanosomal protein synergizes with the cytokines ciliary neurotrophic factor and leukemia inhibitory factor to prevent apoptosis of neuronal cells. Mol. Biol. Cell 2000, 11:1487-1498.
45. Chuenkova M.V., Pereira M.A. The T. cruzi trans-sialidase induces PC12 cell differentiation via MAPK/ERK pathway. Neuroreport 2001, 12:3715-3718.
46. Chuenkova M.V., Pereira M.A. PDNF, a human parasite-derived mimic of neurotrophic factors, prevents caspase activation, free radical formation, and death of dopaminergic cells exposed to the Parkinsonism-inducing neurotoxin MPP+. Brain Res. Mol. Brain Res. 2003, 119:50-61.
47. Chuenkova M.V., PereiraPerrin M. Chagas' disease parasite promotes neuron survival and differentiation through TrkA nerve growth factor receptor. J. Neurochem. 2004, 91:385-394.
48. Chuenkova M.V., PereiraPerrin M. A synthetic peptide modeled on PDNF, Chagas' disease parasite neurotrophic factor, promotes survival and differentiation of neuronal cells through TrkA receptor. Biochemistry 2005, 44:15685-15694.
49. Chuenkova M.V., Pereiraperrin M. Enhancement of tyrosine hydroxylase expression and activity by Trypanosoma cruzi parasite-derived neurotrophic factor. Brain Res. 2006, 1099:167-175.
50. Chuenkova M.V., PereiraPerrin M. Trypanosoma cruzi targets Akt in host cells as an intracellular antiapoptotic strategy. Sci. Signal. 2009, 2. ra74.
51. Chuenkova M., Pereira M., Taylor G. trans-sialidase of Trypanosoma cruzi: location of galactose-binding site(s). Biochem. Biophys. Res. Commun. 1999, 262:549-556.
52. Chuenkova M.V., Furnari F.B., Cavenee W.K., Pereira M.A. Trypanosoma cruzi trans-sialidase: a potent and specific survival factor for human Schwann cells by means of phosphatidylinositol 3-kinase/Akt signaling. Proc. Natl. Acad. Sci. USA 2001, 98:9936-9941.
53. Cole K.K., Perez-Polo J.R. Poly(ADP-ribose) polymerase inhibition prevents both apoptotic-like delayed neuronal death and necrosis after H(2)O(2) injury. J. Neurochem. 2002, 82:19-29.
54. Conti G., Rostami A., Scarpini E., Baron P., Galimberti D., Bresolin N., et al. Inducible nitric oxide synthase (iNOS) in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system. Exp. Neurol. 2004, 187:350-358.
55. Correia D., Junqueira L.F., Molina R.J., Prata A. Cardiac autonomic modulation evaluated by heart interval variability is unaltered but subtly widespread in the indeterminate Chagas' disease. Pacing Clin. Electrophysiol. 2007, 30:772-780.
56. Coura J.R. Chagas disease: what is known and what is needed-a background article. Mem. Inst. Oswaldo. Cruz. 2007, 102(Suppl. 1):113-122.
57. Cunha A.B., Cunha D.M., Pedrosa R.C., Flammini F., Silva A.J., Saad E.A., et al. Norepinephrine and heart rate variability: a marker of dysautonomia in chronic Chagas cardiopathy. Rev. Port. Cardiol. 2003, 22:29-52.
58. da Silveira A.B., Arantes R.M., Vago A.R., Lemos E.M., Adad S.J., Correa-Oliveira R., et al. Comparative study of the presence of Trypanosoma cruzi kDNA, inflammation and denervation in chagasic patients with and without megaesophagus. Parasitology 2005, 131:627-634.
59. da Silveira A.B., D'Avila Reis D., de Oliveira E.C., Neto S.G., Luquetti A.O., Poole D., et al. Neurochemical coding of the enteric nervous system in chagasic patients with megacolon. Dig. Dis. Sci. 2007, 52:2877-2883.
60. da Silveira A.B., Lemos E.M., Adad S.J., Correa-Oliveira R., Furness J.B., D'Avila Reis D. Megacolon in Chagas disease: a study of inflammatory cells, enteric nerves, and glial cells. Hum. Pathol. 2007, 38:1256-1264.
61. da Silveira A.B., Freitas M.A., de Oliveira E.C., Neto S.G., Luquetti A.O., Furness J.B., et al. Neuronal plasticity of the enteric nervous system is correlated with chagasic megacolon development. Parasitology 2008, 135:1337-1342.
62. da Silveira A.B., Freitas M.A., de Oliveira E.C., Neto S.G., Luquetti A.O., Furness J.B., et al. Glial fibrillary acidic protein and S-100 colocalization in the enteroglial cells in dilated and nondilated portions of colon from chagasic patients. Hum. Pathol. 2009, 40:244-251.
63. Dantas R.O., Godoy R.A., Oliveira R.B., Meneghelli U.G., Troncon L.E. Lower esophageal sphincter pressure in Chagas' disease. Dig. Dis. Sci. 1990, 35:508-512.
64. Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997, 91:231-241.
65. Davila D.F., Donis J.H., Torres A., Gottberg C.F., Rossell O. Cardiac parasympathetic innervation in Chagas' heart disease. Med. Hypotheses 1991, 35:80-84.
66. Davila D.F., Gottberg C.F., Torres A., Holzhaker G., Barrios R., Ramoni P., et al. Cardiac sympathetic-parasympathetic balance in rats with experimentally-induced acute chagasic myocarditis. Rev. Inst. Med. Trop. Sao Paulo 1995, 37:155-159.
67. Davila D.F., Inglessis G., Mazzei de Davila C.A. Chagas' heart disease and the autonomic nervous system. Int. J. Cardiol. 1998, 66:123-127.
68. Davila D.F., Donis J.H., Torres A., Ferrer J.A. A modified and unifying neurogenic hypothesis can explain the natural history of chronic Chagas heart disease. Int. J. Cardiol. 2004, 96:191-195.
69. de Lima M.A., Cabrine-Santos M., Tavares M.G., Gerolin G.P., Lages-Silva E., Ramirez L.E. Interstitial cells of Cajal in chagasic megaesophagus. Ann. Diagn. Pathol. 2008, 12:271-274.
70. de Melo-Jorge M., PereiraPerrin M. The Chagas' disease parasite Trypanosoma cruzi exploits nerve growth factor receptor TrkA to infect mammalian hosts. Cell Host Microbe 2007, 1:251-261.
71. de Oliveira R.B., Rezende Filho J., Dantas R.O., Iazigi N. The spectrum of esophageal motor disorders in Chagas' disease. Am. J. Gastroenterol. 1995, 90:1119-1124.
72. de Souza M.M., Andrade S.G., Barbosa A.A., Macedo Santos R.T., Alves V.A., Andrade Z.A. Trypanosoma cruzi strains and autonomic nervous system pathology in experimental Chagas disease. Mem. Inst. Oswaldo Cruz 1996, 91:217-224.
73. Diazgranados C.A., Saavedra-Trujillo C.H., Mantilla M., Valderrama S.L., Alquichire C., Franco-Paredes C. Chagasic encephalitis in HIV patients: common presentation of an evolving epidemiological and clinical association. Lancet Infect. Dis. 2009, 9:324-330.
74. Dutra W.O., Gollob K.J. Current concepts in immunoregulation and pathology of human Chagas disease. Curr. Opin. Infect. Dis. 2008, 21:287-292.
75. El-Sayed N.M., Myler P.J., Bartholomeu D.C., Nilsson D., Aggarwal G., Tran A.N., et al. The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science 2005, 309:409-415.
76. Fazan V.P., Lachat J.J. Qualitative and quantitative morphology of the vagus nerve in experimental Chagas' disease in rats: a light microscopy study. Am. J. Trop. Med. Hyg. 1997, 57:672-677.
77. Feldman S., Garcia G., Svetaz M.J., Avila J.L., Revelli S., Bottasso O.A., et al. Evidence that antisulfatide autoantibodies from rats experimentally infected with Trypanosoma cruzi bind to homologous neural tissue. Parasitol. Res. 1999, 85:446-451.
78. Frasch A.C. Functional diversity in the trans-sialidase and mucin families in Trypanosoma cruzi. Parasitol. Today 2000, 16:282-286.
79. Freire-de-Lima L., Alisson-Silva F., Carvalho S.T., Takiya C.M., Rodrigues M.M., DosReis G.A., et al. Trypanosoma cruzi subverts host cell sialylation and may compromise antigen-specific CD8+ T cell responses. J. Biol. Chem. 2010, 285:13388-13396.
80. Frevert U., Schenkman S., Nussenzweig V. Stage-specific expression and intracellular shedding of the cell surface trans-sialidase of Trypanosoma cruzi. Infect. Immun. 1992, 60:2349-2360.
81. Gao W., Pereira M.A. Trypanosoma cruzi trans-sialidase potentiates T cell activation through antigen-presenting cells: role of IL-6 and Bruton's tyrosine kinase. Eur. J. Immunol. 2001, 31:1503-1512.
82. Gao W., Pereira M.A. Interleukin-6 is required for parasite specific response and host resistance to Trypanosoma cruzi. Int. J. Parasitol. 2002, 32:167-170.
83. Gao W., Wortis H.H., Pereira M.A. The Trypanosoma cruzi trans-sialidase is a T cell-independent B cell mitogen and an inducer of non-specific Ig secretion. Int. Immunol. 2002, 14:299-308.
84. Gao W., Luquetti A.O., Pereira M.A. Immunological tolerance and its breakdown in Chagas' heart disease: role of parasitokines. Front. Biosci. 2003, 8:e218-e227.
85. Gao Y., Deng K., Hou J., Bryson J.B., Barco A., Nikulina E., et al. Activated CREB is sufficient to overcome inhibitors in myelin and promote spinal axon regeneration in vivo. Neuron 2004, 44:609-621.
86. Garcia S.B., Paula J.S., Giovannetti G.S., Zenha F., Ramalho E.M., Zucoloto S., et al. Nitric oxide is involved in the lesions of the peripheral autonomic neurons observed in the acute phase of experimental Trypanosoma cruzi infection. Exp. Parasitol. 1999, 93:191-197.
87. Garg N., Postan M., Mensa-Wilmot K., Tarleton R.L. Glycosylphosphatidylinositols are required for the development of Trypanosoma cruzi amastigotes. Infect. Immun. 1997, 65:4055-4060.
88. Gazzinelli R.T., Denkers E.Y. Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism. Nat. Rev. Immunol. 2006, 6:895-906.
89. Gazzinelli R.T., Oswald I.P., Hieny S., James S.L., Sher A. The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an l-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta. Eur. J. Immunol. 1992, 22:2501-2506.
90. Gea S., Ordonez P., Cerban F., Iosa D., Chizzolini C., Vottero-Cima E. Chagas' disease cardioneuropathy: association of anti-Trypanosoma cruzi and anti-sciatic nerve antibodies. Am. J. Trop. Med. Hyg. 1993, 49:581-588.
91. Ginty D.D., Bonni A., Greenberg M.E. Nerve growth factor activates a Ras-dependent protein kinase that stimulates c-fos transcription via phosphorylation of CREB. Cell 1994, 77:713-725.
92. Gu Z., Nakamura T., Lipton S.A. Redox reactions induced by nitrosative stress mediate protein misfolding and mitochondrial dysfunction in neurodegenerative diseases. Mol. Neurobiol. 2010, 41:55-72.
93. Guerra L.B., Andrade L.O., Galvao L.M., Macedo A.M., Machado C.R. Cyclophosphamide-induced immunosuppression protects cardiac noradrenergic nerve terminals from damage by Trypanosoma cruzi infection in adult rats. Trans. R. Soc. Trop. Med. Hyg. 2001, 95:505-509.
94. Gutierrez B., Osorio L., Motta M.C., Huima-Byron T., Erdjument-Bromage H., Munoz C., et al. Molecular characterization and intracellular distribution of the alpha 5 subunit of Trypanosoma cruzi 20S proteasome. Parasitol. Int. 2009, 58:367-374.
95. Gutierrez F.R., Mineo T.W., Pavanelli W.R., Guedes P.M., Silva J.S. The effects of nitric oxide on the immune system during Trypanosoma cruzi infection. Mem. Inst. Oswaldo Cruz 2009, 104(Suppl. 1):236-245.
96. Ha S., Redmond L. ERK mediates activity dependent neuronal complexity via sustained activity and CREB-mediated signaling. Dev. Neurobiol. 2008, 68:1565-1579.
97. Hagger R., Finlayson C., Kahn F., De Oliveira R., Chimelli L., Kumar D. A deficiency of interstitial cells of Cajal in Chagasic megacolon. J. Auton. Nerv. Syst. 2000, 80:108-111.
98. Haolla F.A., Claser C., de Alencar B.C., Tzelepis F., de Vasconcelos J.R., de Oliveira G., et al. Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection. Vaccine 2009, 27:5644-5653.
99. Hashimoto M., Nakajima-Shimada J., Aoki T. Trypanosoma cruzi posttranscriptionally up-regulates and exploits cellular FLIP for inhibition of death-inducing signal. Mol. Biol. Cell 2005, 16:3521-3528.
100. Herbella F.A., Aquino J.L., Stefani-Nakano S., Artifon E.L., Sakai P., Crema E., et al. Treatment of achalasia: lessons learned with Chagas' disease. Dis. Esophagus 2008, 21:461-467.
101. Hernandez C.C., Barcellos L.C., Gimenez L.E., Cabarcas R.A., Garcia S., Pedrosa R.C., et al. Human chagasic IgGs bind to cardiac muscarinic receptors and impair L-type Ca2+ currents. Cardiovasc. Res. 2003, 58:55-65.
102. Hoff R., Teixeira R.S., Carvalho J.S., Mott K.E. Trypanosoma cruzi in the cerebrospinal fluid during the acute stage of Chagas' disease. N. Engl. J. Med. 1978, 298:604-606.
103. Howlett M., Menheniott T.R., Judd L.M., Giraud A.S. Cytokine signalling via gp130 in gastric cancer. Biochim. Biophys. Acta 2009, 1793:1623-1633.
104. Huang E.J., Reichardt L.F. Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci. 2001, 24:677-736.
105. Iantorno G., Bassotti G., Kogan Z., Lumi C.M., Cabanne A.M., Fisogni S., et al. The enteric nervous system in chagasic and idiopathic megacolon. Am. J. Surg. Pathol. 2007, 31:460-468.
106. Imai K., Mimori T., Kawai M., Koga H. Microarray analysis of host gene-expression during intracellular nests formation of Trypanosoma cruzi amastigotes. Microbiol. Immunol. 2005, 49:623-631.
107. Iosa D., DeQuattro V., Lee D.D., Elkayam U., Palmero H. Plasma norepinephrine in Chagas' cardioneuromyopathy: a marker of progressive dysautonomia. Am. Heart J. 1989, 117:882-887.
108. James T.N., Rossi M.A., Yamamoto S. Postmortem studies of the intertruncal plexus and cardiac conduction system from patients with Chagas disease who died suddenly. Prog. Cardiovasc. Dis. 2005, 47:258-275.
109. Johnson E.O., Charchanti A., Soucacos P.N. Nerve repair: experimental and clinical evaluation of neurotrophic factors in peripheral nerve regeneration. Injury 2008, 39(Suppl. 3):S37-S42.
110. Junqueira L.F., Soares J.D. Impaired autonomic control of heart interval changes to Valsalva manoeuvre in Chagas' disease without overt manifestation. Auton. Neurosci. 2002, 97:59-67.
111. Knott A.B., Bossy-Wetzel E. Nitric oxide in health and disease of the nervous system. Antioxid. Redox Signal. 2009, 11:541-554.
112. Koberle F. Chagas' disease and Chagas' syndromes: the pathology of American trypanosomiasis. Adv. Parasitol. 1968, 6:63-116.
113. Koberle F. The causation and importance of nervous lesions in American trypanosomiasis. Bull. World Health Organ. 1970, 42:739-743.
114. Koeberle F. Enteromegaly and cardiomegaly in chagas disease. Gut 1963, 4:399-405.
115. Koon H.W., Pothoulakis C. Immunomodulatory properties of substance P: the gastrointestinal system as a model. Ann. N. Y. Acad. Sci. 2006, 1088:23-40.
116. Lai K.O., Glass D.J., Geis D., Yancopoulos G.D., Ip N.Y. Structural determinants of Trk receptor specificities using BDNF-based neurotrophin chimeras. J. Neurosci. Res. 1996, 46:618-629.
117. Laranjeira C., Pachnis V. Enteric nervous system development: recent progress and future challenges. Auton. Neurosci. 2009, 151:61-69.
118. Lenzi H.L., Oliveira D.N., Lima M.T., Gattass C.R. Trypanosoma cruzi: paninfectivity of CL strain during murine acute infection. Exp. Parasitol. 1996, 84:16-27.
119. Leon J.S., Engman D.M. The significance of autoimmunity in the pathogenesis of Chagas heart disease. Front. Biosci. 2003, 8:e315-e322.
120. Letai A. Growth factor withdrawal and apoptosis: the middle game. Mol. Cell 2006, 21:728-730.
121. Lo Presti M.S., Rivarola H.W., Fernandez A.R., Enders J.E., Levin G., Fretes R., et al. Involvement of the beta-adrenergic system in the cardiac chronic form of experimental Trypanosoma cruzi infection. Parasitology 2009, 136:905-918.
122. Lo R., Hsia H.H. Ventricular arrhythmias in heart failure patients. Cardiol. Clin. 2008, 26:381-403. vi.
123. Long R.G., Albuquerque R.H., Bishop A.E., Polak J.M., Bloom S.R. The peptidergic system in Chagas's disease. Trans. R. Soc. Trop. Med. Hyg. 1980, 74:273-274. [proceedings].
124. Losavio A., Jones M.C., Sanz O.P., Mirkin G., Gonzalez Cappa S.M., Muchnik S., et al. A sequential study of the peripheral nervous system involvement in experimental Chagas' disease. Am. J. Trop. Med. Hyg. 1989, 41:539-547.
125. Losavio A.S., Sica R.E., Sanz O.P., Mirkin G., Gonzalez Cappa S.M., Muchnik S. Functional changes of the sciatic nerve in mice chronically infected with Trypanosoma cruzi. Medicina (B Aires) 1993, 53:129-132.
126. Lu B., Alroy J., Luquetti A.O., PereiraPerrin M. Human autoantibodies specific for neurotrophin receptors TrkA, TrkB, and TrkC protect against lethal Trypanosoma cruzi infection in mice. Am. J. Pathol. 2008, 173:1406-1414.
127. Lu B., Petrola Z., Luquetti A.O., PereiraPerrin M. Auto-antibodies to receptor tyrosine kinases TrkA, TrkB and TrkC in patients with chronic Chagas' disease. Scand. J. Immunol. 2008, 67:603-609.
128. Luther J.A., Birren S.J. Neurotrophins and target interactions in the development and regulation of sympathetic neuron electrical and synaptic properties. Auton. Neurosci. 2009, 151:46-60.
129. Machado C.R., Ribeiro A.L. Experimental American trypanomiasis in rats: sympathetic denervation, parasitism and inflammatory process. Mem. Inst. Oswaldo Cruz 1989, 84:549-556.
130. Machado A.B., Machado C.R., Gomez M.V. Trypanosoma cruzi: acetylcholine content and cholinergic innervation of the heart in rats. Exp. Parasitol. 1979, 47:107-115.
131. Machado C.R., Gomez M.V., Machado A.B. Changes in choline acetyltransferase activity of rat tissues during Chagas' disease. Braz. J. Med. Biol. Res. 1987, 20:697-702.
132. Machado C.R., de Oliveira D.A., Magalhaes M.J., Carvalho E.M., Ramalho-Pinto F.J. Trypanosoma cruzi infection in rats induced early lesion of the heart noradrenergic nerve terminals by a complement-independent mechanism. J. Neural Transm. Gen. Sect. 1994, 97:149-159.
133. Machado C.R., Caliari M.V., de Lana M., Tafuri W.L. Heart autonomic innervation during the acute phase of experimental American trypanosomiasis in the dog. Am. J. Trop. Med. Hyg. 1998, 59:492-496.
134. Machado E.M., Camilo Junior D.J., Pinheiro S.W., Lopes E.R., Fernandes A.J., Dias J.C., et al. Morphometry of submucous and myenteric esophagic plexus of dogs experimentally reinfected with Trypanosoma cruzi. Mem. Inst. Oswaldo Cruz 2001, 96:545-548.
135. Madison R.D., Archibald S.J. Point sources of Schwann cells result in growth into a nerve entubulation repair site in the absence of axons: effects of freeze-thawing. Exp. Neurol. 1994, 128:266-275.
136. Mady C., Cardoso R.H., Barretto A.C., da Luz P.L., Bellotti G., Pileggi F. Survival and predictors of survival in patients with congestive heart failure due to Chagas' cardiomyopathy. Circulation 1994, 90:3098-3102.
137. Maifrino L.B., Liberti E.A., de Souza R.R. Vasoactive-intestinal-peptide- and substance-P-immunoreactive nerve fibres in the myenteric plexus of mouse colon during the chronic phase of Trypanosoma cruzi infection. Ann. Trop. Med. Parasitol. 1999, 93:49-56.
138. Maifrino L.B., Liberti E.A., Watanabe I., De Souza R.R. Morphometry and acetylcholinesterase activity of the myenteric neurons of the mouse colon in the chronic phase of experimental Trypanosoma cruzi infection. Am. J. Trop. Med. Hyg. 1999, 60:721-725.
139. Manning B.D., Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 2007, 129:1261-1274.
140. Manning-Cela R., Cortes A., Gonzalez-Rey E., Van Voorhis W.C., Swindle J., Gonzalez A. LYT1 protein is required for efficient in vitro infection by Trypanosoma cruzi. Infect. Immun. 2001, 69:3916-3923.
141. Margolis K.G., Gershon M.D. Neuropeptides and inflammatory bowel disease. Curr. Opin. Gastroenterol. 2009, 25:503-511.
142. Marin-Neto J.A. Cardiac dysautonomia and pathogenesis of Chagas' heart disease. Int. J. Cardiol. 1998, 66:129-131.
143. Marin-Neto J.A., Cunha-Neto E., Maciel B.C., Simoes M.V. Pathogenesis of chronic Chagas heart disease. Circulation 2007, 115:1109-1123.
144. Martinelli P.M., Camargos E.R., Azevedo A.A., Chiari E., Morel G., Machado C.R. Cardiac NGF and GDNF expression during Trypanosoma cruzi infection in rats. Auton. Neurosci. 2006, 130:32-40.
145. Matsuda N.M., Oliveira R.B., Dantas R.O., Iazigi N. Effect of isosorbide dinitrate on gastroesophageal reflux in healthy volunteers and patients with Chagas' disease. Dig. Dis. Sci. 1995, 40:177-182.
146. Matsuda N.M., Miller S.M., Evora P.R. The chronic gastrointestinal manifestations of Chagas disease. Clinics (Sao Paulo) 2009, 64:1219-1224.
147. Maurer U., Charvet C., Wagman A.S., Dejardin E., Green D.R. Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol. Cell 2006, 21:749-760.
148. Melo R.C., Machado C.R. Depletion of radiosensitive leukocytes exacerbates the heart sympathetic denervation and parasitism in experimental Chagas' disease in rats. J. Neuroimmunol. 1998, 84:151-157.
149. Melo R.C., Machado C.R. Trypanosoma cruzi: peripheral blood monocytes and heart macrophages in the resistance to acute experimental infection in rats. Exp. Parasitol. 2001, 97:15-23.
150. Meneghelli U.G. Chagasic enteropathy. Rev. Soc. Bras. Med. Trop. 2004, 37:252-260.
151. Meyer H., Machado R.D., Cintra W.M. On the cultivation of Trypanosoma cruzi in tissue cultures of the spinal and sympathetic ganglion from the chick embryo. An Acad. Bras. Cienc. 1982, 54:739-742.
152. Meyer M., Matsuoka I., Wetmore C., Olson L., Thoenen H. Enhanced synthesis of brain-derived neurotrophic factor in the lesioned peripheral nerve: different mechanisms are responsible for the regulation of BDNF and NGF mRNA. J. Cell Biol. 1992, 119:45-54.
153. Ming M., Chuenkova M., Ortega-Barria E., Pereira M.E. Mediation of Trypanosoma cruzi invasion by sialic acid on the host cell and trans-sialidase on the trypanosome. Mol. Biochem. Parasitol. 1993, 59:243-252.
154. Mizuno T., Zhang G., Takeuchi H., Kawanokuchi J., Wang J., Sonobe Y., et al. Interferon-gamma directly induces neurotoxicity through a neuron specific, calcium-permeable complex of IFN-gamma receptor and AMPA GluR1 receptor. FASEB J. 2008, 22:1797-1806.
155. Molina H.A., Cardoni R.L., Rimoldi M.T. The neuromuscular pathology of experimental Chagas' disease. J. Neurol. Sci. 1987, 81:287-300.
156. Mucci J., Risso M.G., Leguizamon M.S., Frasch A.C., Campetella O. The trans-sialidase from Trypanosoma cruzi triggers apoptosis by target cell sialylation. Cell. Microbiol. 2006, 8:1086-1095.
157. Mukherjee S., Huang H., Weiss L.M., Costa S., Scharfstein J., Tanowitz H.B. Role of vasoactive mediators in the pathogenesis of Chagas' disease. Front. Biosci. 2003, 8:e410-e419.
158. Mukherjee S., Huang H., Petkova S.B., Albanese C., Pestell R.G., Braunstein V.L., et al. Trypanosoma cruzi infection activates extracellular signal-regulated kinase in cultured endothelial and smooth muscle cells. Infect. Immun. 2004, 72:5274-5282.
159. Mukherjee S., Nagajyothi F., Mukhopadhyay A., Machado F.S., Belbin T.J., Campos de Carvalho A., et al. Alterations in myocardial gene expression associated with experimental Trypanosoma cruzi infection. Genomics 2008, 91:423-432.
160. Murata E., Hashimoto M., Aoki T. Interaction between cFLIP and Itch, a ubiquitin ligase, is obstructed in Trypanosoma cruzi-infected human cells. Microbiol. Immunol. 2008, 52:539-543.
161. Nagata K. Studies of the structure-activity relationships of peptides and proteins involved in growth and development based on their three-dimensional structures. Biosci. Biotechnol. Biochem. 2010, 74:462-470.
162. Nascimento R.D., de Souza Lisboa A., Fujiwara R.T., de Freitas M.A., Adad S.J., Oliveira R.C., et al. Characterization of enteroglial cells and denervation process in chagasic patients with and without megaesophagus. Hum. Pathol. 2010, 41:528-534.
163. Navarro X., Vivo M., Valero-Cabre A. Neural plasticity after peripheral nerve injury and regeneration. Prog. Neurobiol. 2007, 82:163-201.
164. O'Connell L., Hongo J.A., Presta L.G., Tsoulfas P. TrkA amino acids controlling specificity for nerve growth factor. J. Biol. Chem. 2000, 275:7870-7877.
165. Oliveira J.S. A natural human model of intrinsic heart nervous system denervation: Chagas' cardiopathy. Am. Heart J. 1985, 110:1092-1098.
166. Oliveira E.C., Fujisawa M.M., Hallal Longo D.E., Farias A.S., Contin Moraes J., Guariento M.E., et al. Neuropathy of gastrointestinal Chagas' disease: immune response to myelin antigens. Neuroimmunomodulation 2009, 16:54-62.
167. Olshansky B., Sabbah H.N., Hauptman P.J., Colucci W.S. Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy. Circulation 2008, 118:863-871.
168. Parodi A.J., Pollevick G.D., Mautner M., Buschiazzo A., Sanchez D.O., Frasch A.C. Identification of the gene(s) coding for the trans-sialidase of Trypanosoma cruzi. EMBO J. 1992, 11:1705-1710.
169. Peraza-Cruces K., Gutierrez-Guedez L., Castaneda Perozo D., Lankford C.R., Rodriguez-Bonfante C., Bonfante-Cabarcas R. Trypanosoma cruzi infection induces up-regulation of cardiac muscarinic acetylcholine receptors in vivo and in vitro. Braz. J. Med. Biol. Res. 2008, 41:796-803.
170. Pereira M.E. A developmentally regulated neuraminidase activity in Trypanosoma cruzi. Science 1983, 219:1444-1446.
171. Perez-Fuentes R., Sanchez-Guillen M.C., Gonzalez-Alvarez C., Monteon V.M., Reyes P.A., Rosales-Encina J.L. Humoral nitric oxide levels and antibody immune response of symptomatic and indeterminate Chagas' disease patients to commercial and autochthonous Trypanosoma cruzi antigen. Am. J. Trop. Med. Hyg. 1998, 58:715-720.
172. Petersen C.A., Krumholz K.A., Carmen J., Sinai A.P., Burleigh B.A. Trypanosoma cruzi infection and nuclear factor kappa B activation prevent apoptosis in cardiac cells. Infect. Immun. 2006, 74:1580-1587.
173. Pinto N.X., Torres-Hillera M.A., Mendoza E., Leon-Sarmiento F.E. Immune response, nitric oxide, autonomic dysfunction and stroke: a puzzling linkage on Trypanosoma cruzi infection. Med. Hypotheses 2002, 58:374-377.
174. Pittella J.E. Central nervous system involvement in Chagas' disease. An updating. Rev. Inst. Med. Trop. Sao Paulo 1993, 35:111-116.
175. Punukollu G., Gowda R.M., Khan I.A., Navarro V.S., Vasavada B.C. Clinical aspects of the Chagas' heart disease. Int. J. Cardiol. 2007, 115:279-283.
176. Rassi A., Rassi A., Little W.C. Chagas' heart disease. Clin. Cardiol. 2000, 23:883-889.
177. Ratier L., Urrutia M., Paris G., Zarebski L., Frasch A.C., Goldbaum F.A. Relevance of the diversity among members of the Trypanosoma cruzi trans-sialidase family analyzed with camelids single-domain antibodies. PLoS One 2008, 3:e3524.
178. Ribeiro U., Safatle-Ribeiro A.V., Habr-Gama A., Gama-Rodrigues J.J., Sohn J., Reynolds J.C. Effect of Chagas' disease on nitric oxide-containing neurons in severely affected and unaffected intestine. Dis. Colon Rectum 1998, 41:1411-1417.
179. Ribeiro A.L., Moraes R.S., Ribeiro J.P., Ferlin E.L., Torres R.M., Oliveira E., et al. Parasympathetic dysautonomia precedes left ventricular systolic dysfunction in Chagas disease. Am. Heart J. 2001, 141:260-265.
180. Ribeiro A.L., Lombardi F., Sousa M.R., Rocha M.O. Vagal dysfunction in Chagas disease. Int. J. Cardiol. 2005, 103:225-226. author reply 227-229.
181. Rocha N.N., Garcia S., Gimenez L.E., Hernandez C.C., Senra J.F., Lima R.S., et al. Characterization of cardiopulmonary function and cardiac muscarinic and adrenergic receptor density adaptation in C57BL/6 mice with chronic Trypanosoma cruzi infection. Parasitology 2006, 133:729-737.
182. Rodrigues E., Liberti E.A., Maifrino L.B., de Souza R.R. Cardiac denervation in mice infected with Trypanosoma cruzi. Ann. Trop. Med. Parasitol. 2002, 96:125-130.
183. Roux P.P., Barker P.A. Neurotrophin signaling through the p75 neurotrophin receptor. Prog. Neurobiol. 2002, 67:203-233.
184. Rubin-de-Celis S.S., Uemura H., Yoshida N., Schenkman S. Expression of trypomastigote trans-sialidase in metacyclic forms of Trypanosoma cruzi increases parasite escape from its parasitophorous vacuole. Cell. Microbiol. 2006, 8:1888-1898.
185. Ruhl A. Glial regulation of neuronal plasticity in the gut: implications for clinicians. Gut 2006, 55:600-602.
186. Saavedra E., Herrera M., Gao W., Uemura H., Pereira M.A. The Trypanosoma cruzi trans-sialidase, through its COOH-terminal tandem repeat, upregulates interleukin 6 secretion in normal human intestinal microvascular endothelial cells and peripheral blood mononuclear cells. J. Exp. Med. 1999, 190:1825-1836.
187. Sahenk Z., Galloway G., Edwards C., Malik V., Kaspar B.K., Eagle A., et al. TrkB and TrkC agonist antibodies improve function, electrophysiologic and pathologic features in Trembler J mice. Exp. Neurol. 2010, 224:495-506.
188. Sakamoto K.M., Frank D.A. CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapy. Clin. Cancer Res. 2009, 15:2583-2587.
189. Schenkman S., Pontes de Carvalho L., Nussenzweig V. Trypanosoma cruzi trans-sialidase and neuraminidase activities can be mediated by the same enzymes. J. Exp. Med. 1992, 175:567-575.
190. Scudder P., Doom J.P., Chuenkova M., Manger I.D., Pereira M.E. Enzymatic characterization of beta-d-galactoside alpha 2,3-trans-sialidase from Trypanosoma cruzi. J. Biol. Chem. 1993, 268:9886-9891.
191. Seeburg D.P., Pak D., Sheng M. Polo-like kinases in the nervous system. Oncogene 2005, 24:292-298.
192. Segal R.A. Selectivity in neurotrophin signaling: theme and variations. Annu. Rev. Neurosci. 2003, 26:299-330.
193. Shen H.M., Pervaiz S. TNF receptor superfamily-induced cell death: redox-dependent execution. FASEB J. 2006, 20:1589-1598.
194. Sheu J.Y., Kulhanek D.J., Eckenstein F.P. Differential patterns of ERK and STAT3 phosphorylation after sciatic nerve transection in the rat. Exp. Neurol. 2000, 166:392-402.
195. Silva J.S., Machado F.S., Martins G.A. The role of nitric oxide in the pathogenesis of Chagas disease. Front. Biosci. 2003, 8:s314-s325.
196. Silveira E.L., Claser C., Haolla F.A., Zanella L.G., Rodrigues M.M. Novel protective antigens expressed by Trypanosoma cruzi amastigotes provide immunity to mice highly susceptible to Chagas' disease. Clin. Vaccine Immunol. 2008, 15:1292-1300.
197. Simeonidis S., Castagliuolo I., Pan A., Liu J., Wang C.C., Mykoniatis A., et al. Regulation of the NK-1 receptor gene expression in human macrophage cells via an NF-kappa B site on its promoter. Proc. Natl. Acad. Sci. USA 2003, 100:2957-2962.
198. Simoes M.V., Pintya A.O., Bromberg-Marin G., Sarabanda A.V., Antloga C.M., Pazin-Filho A., et al. Relation of regional sympathetic denervation and myocardial perfusion disturbance to wall motion impairment in Chagas' cardiomyopathy. Am. J. Cardiol. 2000, 86:975-981.
199. Skoff A.M., Lisak R.P., Bealmear B., Benjamins J.A. TNF-alpha and TGF-beta act synergistically to kill Schwann cells. J. Neurosci. Res. 1998, 53:747-756.
200. Soares M.B., Santos R.R. Immunopathology of cardiomyopathy in the experimental Chagas disease. Mem. Inst. Oswaldo Cruz 1999, 94(Suppl. 1):257-262.
201. Sofroniew M.V., Howe C.L., Mobley W.C. Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci. 2001, 24:1217-1281.
202. Sterin-Borda L., Borda E. Role of neurotransmitter autoantibodies in the pathogenesis of chagasic peripheral dysautonomia. Ann. N. Y. Acad. Sci. 2000, 917:273-280.
203. Sterin-Borda L., Leiros C.P., Goin J.C., Cremaschi G., Genaro A., Echague A.V., et al. Participation of nitric oxide signaling system in the cardiac muscarinic cholinergic effect of human chagasic IgG. J. Mol. Cell. Cardiol. 1997, 29:1851-1865.
204. Tafuri W.L., Maria Tde A. On the behavior of the neurosecretory vesicular component of the mega-esophagus in human Trypanosomiasis cruzi. Rev. Inst. Med. Trop. Sao Paulo 1970, 12:298-309.
205. Tanowitz H.B., Brosnan C., Guastamacchio D., Baron G., Raventos-Suarez C., Bornstein M., et al. Infection of organotypic cultures of spinal cord and dorsal root ganglia with Trypanosoma cruzi. Am. J. Trop. Med. Hyg. 1982, 31:1090-1097.
206. Tanowitz H.B., Machado F.S., Jelicks L.A., Shirani J., de Carvalho A.C., Spray D.C., et al. Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease). Prog. Cardiovasc. Dis. 2009, 51:524-539.
207. Tarleton R.L. Parasite persistence in the aetiology of Chagas disease. Int. J. Parasitol. 2001, 31:550-554.
208. Tekiel V.S., Mirkin G.A., Gonzalez Cappa S.M. Chagas' disease: reactivity against homologous tissues induced by different strains of Trypanosoma cruzi. Parasitology 1997, 115(Pt 5):495-502.
209. Tekiel V., Losavio A., Jones M., Muchnik S., Gonzalez-Cappa S.M. Changes in the mouse sciatic nerve action potential after epineural injection of sera from Trypanosoma cruzi infected mice. Parasite Immunol. 2001, 23:533-539.
210. Todeschini A.R., Dias W.B., Girard M.F., Wieruszeski J.M., Mendonca-Previato L., Previato J.O. Enzymatically inactive trans-sialidase from Trypanosoma cruzi binds sialyl and beta-galactopyranosyl residues in a sequential ordered mechanism. J. Biol. Chem. 2004, 279:5323-5328.
211. Tracey K.J. Physiology and immunology of the cholinergic antiinflammatory pathway. J. Clin. Invest. 2007, 117:289-296.
212. Tucker K.L., Meyer M., Barde Y.A. Neurotrophins are required for nerve growth during development. Nat. Neurosci. 2001, 4:29-37.
213. Twiss J.L., Chang J.H., Schanen N.C. Pathophysiological mechanisms for actions of the neurotrophins. Brain Pathol. 2006, 16:320-332.
214. Urfer R., Tsoulfas P., O'Connell L., Shelton D.L., Parada L.F., Presta L.G. An immunoglobulin-like domain determines the specificity of neurotrophin receptors. EMBO J. 1995, 14:2795-2805.
215. Vaillant A.R., Zanassi P., Walsh G.S., Aumont A., Alonso A., Miller F.D. Signaling mechanisms underlying reversible, activity-dependent dendrite formation. Neuron 2002, 34:985-998.
216. Van Voorhis W.C., Schlekewy L., Trong H.L. Molecular mimicry by Trypanosoma cruzi: the F1-160 epitope that mimics mammalian nerve can be mapped to a 12-amino acid peptide. Proc. Natl. Acad. Sci. USA 1991, 88:5993-5997.
217. Vasconcelos D.F., Junqueira L.F. Distinctive impaired cardiac autonomic modulation of heart rate variability in chronic Chagas' indeterminate and heart diseases. J. Electrocardiol. 2009, 42:281-289.
218. Vawter M.P., Basaric-Keys J., Li Y., Lester D.S., Lebovics R.S., Lesch K.P., et al. Human olfactory neuroepithelial cells: tyrosine phosphorylation and process extension are increased by the combination of IL-1beta, IL-6, NGF, and bFGF. Exp. Neurol. 1996, 142:179-194.
219. Villalta F., Zhang Y., Bibb K.E., Pratap S., Burns J.M., Lima M.F. Signal transduction in human macrophages by gp83 ligand of Trypanosoma cruzi: trypomastigote gp83 ligand up-regulates trypanosome entry through protein kinase C activation. Mol. Cell Biol. Res. Commun. 1999, 2:64-70.
220. Villar J.C., Leon H., Morillo C.A. Cardiovascular autonomic function testing in asymptomatic T. cruzi carriers: a sensitive method to identify subclinical Chagas' disease. Int. J. Cardiol. 2004, 93:189-195.
221. Vo P.A., Tomlinson D.R. The regeneration of peripheral noradrenergic nerves after chemical sympathectomy in diabetic rats: effects of nerve growth factor. Exp. Neurol. 1999, 157:127-134.
222. von Boyen G.B., Steinkamp M., Geerling I., Reinshagen M., Schafer K.H., Adler G., et al. Proinflammatory cytokines induce neurotrophic factor expression in enteric glia: a key to the regulation of epithelial apoptosis in Crohn's disease. Inflamm. Bowel Dis. 2006, 12:346-354.
223. Vyas S., Biguet N.F., Michel P.P., Monaco L., Foulkes N.S., Evan G.I., et al. Molecular mechanisms of neuronal cell death: implications for nuclear factors responding to cAMP and phorbol esters. Mol. Cell. Neurosci. 2002, 21:1-14.
224. Weinkauf C., Pereiraperrin M. Trypanosoma cruzi promotes neuronal and glial cell survival through the neurotrophic receptor TrkC. Infect. Immun. 2009, 77:1368-1375.
225. Wen J.J., Yachelini P.C., Sembaj A., Manzur R.E., Garg N.J. Increased oxidative stress is correlated with mitochondrial dysfunction in chagasic patients. Free Radic. Biol. Med. 2006, 41:270-276.
226. Wiesmann C., Ultsch M.H., Bass S.H., de Vos A.M. Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor. Nature 1999, 401:184-188.
227. Wong V., Glass D.J., Arriaga R., Yancopoulos G.D., Lindsay R.M., Conn G. Hepatocyte growth factor promotes motor neuron survival and synergizes with ciliary neurotrophic factor. J. Biol. Chem. 1997, 272:5187-5191.
228. Woronowicz A., De Vusser K., Laroy W., Contreras R., Meakin S.O., Ross G.M., et al. Trypanosome trans-sialidase targets TrkA tyrosine kinase receptor and induces receptor internalization and activation. Glycobiology 2004, 14:987-998.
229. Woronowicz A., Amith S.R., Davis V.W., Jayanth P., De Vusser K., Laroy W., et al. Trypanosome trans-sialidase mediates neuroprotection against oxidative stress, serum/glucose deprivation, and hypoxia-induced neurite retraction in Trk-expressing PC12 cells. Glycobiology 2007, 17:725-734.
230. Yaffe M.B., Elia A.E. Phosphoserine/threonine-binding domains. Curr. Opin. Cell Biol. 2001, 13:131-138.
231. Yuan J., Yankner B.A. Apoptosis in the nervous system. Nature 2000, 407:802-809.
232. Yuan Z.Q., Feldman R.I., Sun M., Olashaw N.E., Coppola D., Sussman G.E., et al. Inhibition of JNK by cellular stress- and tumor necrosis factor alpha-induced AKT2 through activation of the NF kappa B pathway in human epithelial cells. J. Biol. Chem. 2002, 277:29973-29982.
233. Zhang L., Tarleton R.L. Parasite persistence correlates with disease severity and localization in chronic Chagas' disease. J. Infect. Dis. 1999, 180:480-486.
234. Zheng M., Kuffler D.P. Guidance of regenerating motor axons in vivo by gradients of diffusible peripheral nerve-derived factors. J. Neurobiol. 2000, 42:212-219.
235. Zheng W.H., Kar S., Quirion R. FKHRL1 and its homologs are new targets of nerve growth factor Trk receptor signaling. J. Neurochem. 2002, 80:1049-1061.
236. Zhou F.Q., Zhou J., Dedhar S., Wu Y.H., Snider W.D. NGF-induced axon growth is mediated by localized inactivation of GSK-3beta and functions of the microtubule plus end binding protein APC. Neuron 2004, 42:897-912.